Sort:
Original Article Issue
Comparison of brain delivery efficiency of diverse formulations administered via cervical lymph node needle-free injection
Military Medical Sciences 2026, 50(4): 268-276
Published: 25 April 2026
Abstract PDF (4.7 MB) Collect
Downloads:1
Objective

To investigate the efficacy of needle-free injection (NFIT) through cervical lymph nodes as a novel strategy for drug delivery into the brain, and compare its efficiency for different drugs.

Methods

Using Evans blue as an injectant in vitro, the differences in drug diffusion between NFIT and needle-dependent injection were studied. By using sodium fluorescein as an injectant in vivo, the tissue distribution of sodium fluorescein in mice over time was evaluated after injection by different means before the dynamic changes of drug accumulation in the brain and lymphatic tissues were observed. Three representative drugs-cyanine5.5 (Cy5.5, a small molecule compound), Cy5.5-bovine serum albumin (Cy5.5-BSA, a protein drug), and Cy5.5-hyaluronic acid (Cy5.5-HA, a high molecular weight polymer) were used to evaluate the brain delivery efficiency of different drugs via NFIT.

Results

In vitro diffusion experiments found a more rapid and uniform diffusion of drugs after NFIT while in vivo experiments showed that the delivery efficiency of fluorescein sodium through intracervical lymphatic NFIT was significantly higher in the cortex and hippocampus of mice than with traditional injection methods. A comparison of three representative drugs confirmed that intracervical lymphatic NFIT was an effective way to deliver small molecule compounds and protein drugs to the brain, but was not workable for polymers of high molecular mass.

Conclusion

Intracervical lymphatic NFIT can efficiently mediate the brain delivery of small molecules and protein drugs, which promises to be a drug delivery method for the application of such drugs to the brain.

Review Issue
Cannabidiol and treatment of depression:an exploration of cutting-edge mechanisms based on blood-brain barrier repair
Military Medical Sciences 2026, 50(1): 58-63
Published: 25 January 2026
Abstract PDF (472.1 KB) Collect
Downloads:2

Depression is a common mental disorder, the pathogenesis of which involves such factors as the imbalance of the monoamine system, neuroinflammation, and oxidative stress. Depression has been found to be associated with dysfunction in the blood-brain barrier (BBB). In recent years, cannabidiol (CBD) has attracted extensive attention due to its remarkable antidepressant activity and neuroprotective properties. Of particular interest is the possibility that CBD may combat depression by repairing BBB damage and thereby improving the homeostasis of the central nervous system. Based on recent research findings, this article explores the antidepressant mechanisms of CBD, the BBB damage in depression, and the protective effects of CBD on the BBB. It is expected to provide references for subsequent studies on the mechanisms of BBB damage in depression and the discovery of new antidepressant targets.

Total 2